A network meta-analysis of randomized controlled trials of biologics for rheumatoid arthritis: a Cochrane overview.
about
Systemic safety of bevacizumab versus ranibizumab for neovascular age-related macular degenerationAdverse effects of biologics: a network meta-analysis and Cochrane overviewAdverse effects of biologics: a network meta-analysis and Cochrane overviewEfficacy and safety of biological agents for systemic juvenile idiopathic arthritis: a systematic review and meta-analysis of randomized trialsRate of discontinuation and drug survival of biologic therapies in rheumatoid arthritis: a systematic review and meta-analysis of drug registries and health care databasesRecent insights into the role of autophagy in the pathogenesis of rheumatoid arthritisSpanish Rheumatology Society and Hospital Pharmacy Society Consensus on recommendations for biologics optimization in patients with rheumatoid arthritis, ankylosing spondylitis and psoriatic arthritisAdvances in the treatment of rheumatoid arthritis.Comparative efficacy of biologics as monotherapy and in combination with methotrexate on patient reported outcomes (PROs) in rheumatoid arthritis patients with an inadequate response to conventional DMARDs--a systematic review and network meta-analyIdentification of S100A9 as biomarker of responsiveness to the methotrexate/etanercept combination in rheumatoid arthritis using a proteomic approachEffect of combination therapy on joint destruction in rheumatoid arthritis: a network meta-analysis of randomized controlled trialsComparing Effects of Biologic Agents in Treating Patients with Rheumatoid Arthritis: A Multiple Treatment Comparison Regression AnalysisIncrease in circulating Th17 cells during anti-TNF therapy is associated with ultrasonographic improvement of synovitis in rheumatoid arthritisBiological drugs for the treatment of rheumatoid arthritis by the subcutaneous route: interpreting efficacy data to assess statistical equivalence.Random-effects meta-analysis for systematic reviews of phase I clinical trials: Rare events and missing data.Comparative efficacy of biological agents in methotrexate-refractory rheumatoid arthritis patients: a Bayesian mixed treatment comparison.Pre-silencing of genes involved in the electron transport chain (ETC) pathway is associated with responsiveness to abatacept in rheumatoid arthritis.[The safety of biologics : a risk-benefit assessment of treating rheumatoid arthritis with biologics based on registry data on mortality].Smoking and outcomes after knee and hip arthroplasty: a systematic reviewCross-cultural validation of the Educational Needs Assessment Tool in RA in 7 European countries.Antipsychotic treatment for children and adolescents with schizophrenia spectrum disorders: protocol for a network meta-analysis of randomised trials.Comparative efficacy and tolerability of anti-epileptic drugs for refractory focal epilepsy: systematic review and network meta-analysis reveals the need for long term comparator trialsDiscontinuation of infliximab therapy in patients with Crohn's disease in sustained complete remission (the STOP IT study): protocol for a double-blind, randomised, placebo-controlled, multicentre trialGraphical tools for network meta-analysis in STATA.Infliximab: 12 years of experienceThe comparative risk of serious infections among rheumatoid arthritis patients starting or switching biological agentsTumour necrosis factor inhibitors versus combination intensive therapy with conventional disease modifying anti-rheumatic drugs in established rheumatoid arthritis: TACIT non-inferiority randomised controlled trial.Choice of Biologic Therapy for Patients with Rheumatoid Arthritis: The Infection Perspective.Disease activity guided dose reduction and withdrawal of adalimumab or etanercept compared with usual care in rheumatoid arthritis: open label, randomised controlled, non-inferiority trial.The impact of steroids, methotrexate, and biologics on clinical and radiographic outcomes in patients with rheumatoid arthritis undergoing fusions at the craniovertebral junction.Application of a validated algorithm to estimate the effectiveness and cost of biologics for rheumatoid arthritis in the US pharmacy benefit manager context.Evaluating the efficacy of sequential biologic therapies for rheumatoid arthritis patients with an inadequate response to tumor necrosis factor-α inhibitorsRisk of hospitalised infection in rheumatoid arthritis patients receiving biologics following a previous infection while on treatment with anti-TNF therapy.Most Trial Eligibility Criteria and Patient Baseline Characteristics Do Not Modify Treatment Effect in Trials Using Targeted Therapies for Rheumatoid Arthritis: A Meta-Epidemiological Study.Safety and effectiveness responses to etanercept for rheumatoid arthritis in Japan: a sub-analysis of a post-marketing surveillance study focusing on the duration of rheumatoid arthritis.Drug usage analysis and health care resources consumption in naïve patients with rheumatoid arthritis.Biologic TNF inhibiting agents for treatment of inflammatory rheumatic diseases: dosing patterns and related costs in Switzerland from a payers perspectiveUse of biologics in a patient with rheumatoid arthritis refractory to methotrexate.A five-year model to assess the early cost-effectiveness of new diagnostic tests in the early diagnosis of rheumatoid arthritisPatient Perceptions and Preferences of Two Etanercept Autoinjectors for Rheumatoid Arthritis: Findings from a Patient Survey in Europe.
P2860
Q24193614-87CCA9BD-995C-4033-A76B-9B3AC42BDB73Q24234197-5A57B5C7-5E9D-45FE-88B8-9E2BE6871574Q24235218-C1A6A94E-356D-467C-B0B4-9FA4CCD01A69Q26775512-10C63772-5A88-409C-BD57-7CDDD118ECBCQ26778600-96A2B928-030B-4CBB-BE86-9B1FFD0B611FQ26784021-44C5DE00-7ECD-413F-870B-FA4456752A70Q26852081-43F88F3A-98F8-48A3-9EB9-68F67E8C045BQ27691822-FB165859-0444-4092-B69A-B5C44DC4A225Q27694496-48435D13-058E-47A2-A32D-6E8C5AC84B0BQ28542901-E1D1941C-6460-443F-8457-E7063D742683Q28543128-1F7D4614-2AEF-48E6-A46C-BA70934EE016Q28547851-171D4F3E-282B-43A3-8974-D1E3E245DF57Q30832987-BB2E0F8A-27D5-4400-968E-691963AC22F2Q30872562-4D43132B-22FA-46BD-BABD-2D12BAE7C7AEQ31107166-7CFD4D94-A0E6-4DBB-A228-FD6A535037E2Q33690668-2CBFF6F1-AE8C-4D27-8BC2-10715004B5B9Q33730446-7328D201-D407-4923-B9EA-9BDC19AE890FQ33743130-55D0E975-8754-4B3E-A2FE-43E07CA79952Q33776622-3EE28F5C-8ACC-489E-9C6D-451DF429DF13Q33910506-55BAFC06-A1AB-4E5A-92EA-2CE1D11897C1Q34327978-E605716F-126D-4B2F-BD72-080ED4960A6DQ34563933-FE042C40-1E4A-44E0-9819-66C4380B06D8Q34767921-9040C1DA-A4E7-41E7-B6A3-618FAC157795Q35009612-ED179979-E882-4EB3-AC61-FC22E9D2789BQ35070446-5989EFB8-B8E4-4291-9278-A60982276AC7Q35082559-68AF3847-A8C4-4996-9021-94EE733F12E8Q35174817-1C2948B0-1214-43E2-992A-5F94AD85215EQ35237588-79446E7C-5162-4364-8A2D-8DD3D59ABCC4Q35348182-F64B6E12-A9DF-44C4-9D18-706FD18958B5Q35590542-657B332E-F6BF-4B0A-882A-B41DD3E9EDCDQ35617540-21E3E543-62AB-47A3-A52D-806A1E30FF4FQ35620336-B1081D24-FDE3-49A0-A39C-351359B2908CQ35636624-61061610-3F87-4797-8097-76FC181C9BC9Q35770656-3A6F022C-2189-48CD-A6D6-D9F53F8A2D6EQ35999139-D10240B1-8DAD-4891-9059-5CFB38DF8631Q36274355-86258ACC-BADE-4E68-A722-EC6C98E5598CQ36439036-222FA4FD-3497-43C9-8031-FC6E21BFC4B4Q36923376-EB8B7470-5117-4D24-B6EF-3F549DA7945BQ36994587-3705937B-D7A8-46CD-B380-D5782851F34FQ37453045-ECC02B87-76A0-4588-9B6E-87EC6966A8E4
P2860
A network meta-analysis of randomized controlled trials of biologics for rheumatoid arthritis: a Cochrane overview.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh
2009年學術文章
@zh-hant
name
A network meta-analysis of ran ...... rthritis: a Cochrane overview.
@en
A network meta-analysis of ran ...... rthritis: a Cochrane overview.
@nl
type
label
A network meta-analysis of ran ...... rthritis: a Cochrane overview.
@en
A network meta-analysis of ran ...... rthritis: a Cochrane overview.
@nl
prefLabel
A network meta-analysis of ran ...... rthritis: a Cochrane overview.
@en
A network meta-analysis of ran ...... rthritis: a Cochrane overview.
@nl
P2093
P2860
P50
P356
P1476
A network meta-analysis of ran ...... rthritis: a Cochrane overview.
@en
P2093
Elizabeth Tanjong Ghogomu
George A Wells
Maria E Suarez-Almazor
Robin Christensen
P2860
P304
P356
10.1503/CMAJ.091391
P407
P577
2009-11-02T00:00:00Z